Lexicon Pharmaceuticals (LXRX) Earnings Date, Estimates & Call Transcripts $0.68 -0.06 (-7.76%) (As of 04:00 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Lexicon Pharmaceuticals Latest Earnings SummaryActual EPS (Nov. 12) -$0.18 Missed By -$0.01 Consensus EPS (Nov. 12) -$0.17 Lexicon Pharmaceuticals posted Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.18, which missed the consensus estimate of -$0.17 by $0.01. Quarterly revenue was reported to be $1.75 million, below analyst estimates of $3.14 million. With a trailing EPS of -$0.75, Lexicon Pharmaceuticals' earnings are expected to grow next year, from ($0.66) to ($0.45) per share. Conference CallConference Call TranscriptSEC 10-Q/10-K FilingPowered by Get Lexicon Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lexicon Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataLXRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LXRX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Lexicon Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.13-$0.13-$0.13Q2 20242-$0.18-$0.13-$0.16Q3 20242-$0.16-$0.15-$0.16Q4 20242-$0.15-$0.07-$0.11FY 20247($0.62)($0.48)($0.55) Lexicon Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/12/2024Q3 2024-$0.17-$0.18 -$0.01-$0.18$3.14M$1.75M8/1/2024Q2 2024-$0.18-$0.17+$0.01-$0.17$2.74M$1.65M5/2/2024Q1 2024-$0.18-$0.20 -$0.02-$0.20$1.17M$1.13M3/11/2024Q4 2023-$0.23-$0.20+$0.03-$0.20$0.68M$0.70M11/8/2023Q3 2023-$0.22-$0.21+$0.01-$0.21$1.49M$0.16M8/3/2023Q2 2023-$0.17-$0.22 -$0.05-$0.22$0.30M$0.32M Get the Latest News and Ratings for LXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexicon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/2/2023Q1 2023-$0.17-$0.17--$0.17-$0.02M3/2/2023Q4 2022-$0.14-$0.16 -$0.02-$0.16-$0.03M Lexicon Pharmaceuticals Earnings - Frequently Asked Questions When did Lexicon Pharmaceuticals announce their last quarterly earnings? Lexicon Pharmaceuticals (NASDAQ:LXRX) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on LXRX's earnings history. Did Lexicon Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Lexicon Pharmaceuticals (NASDAQ:LXRX) missed the analysts' consensus estimate of ($0.17) by $0.01 with a reported earnings per share (EPS) of ($0.18). Learn more on analysts' earnings estimate vs. LXRX's actual earnings. How can I listen to Lexicon Pharmaceuticals's earnings conference call? The conference call for Lexicon Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Lexicon Pharmaceuticals's conference call transcript? The conference call transcript for Lexicon Pharmaceuticals's latest earnings report can be read online. Read Transcript How can I view Lexicon Pharmaceuticals's earnings report? Lexicon Pharmaceuticals's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Lexicon Pharmaceuticals generate each year? Lexicon Pharmaceuticals (NASDAQ:LXRX) has a recorded annual revenue of $5.23 million. How much profit does Lexicon Pharmaceuticals generate each year? Lexicon Pharmaceuticals (NASDAQ:LXRX) has a recorded net income of -$177.12 million. LXRX has generated -$0.75 earnings per share over the last four quarters. What is Lexicon Pharmaceuticals's EPS forecast for next year? Lexicon Pharmaceuticals's earnings are expected to grow from ($0.66) per share to ($0.45) per share in the next year. More Earnings Resources from MarketBeat Related Companies IRWD Earnings SGMO Earnings EBS Earnings CDXS Earnings RIGL Earnings XOMA Earnings VNDA Earnings VSTM Earnings ACHV Earnings RGLS Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. This page (NASDAQ:LXRX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored“The Last Retirement Stock You’ll Ever Need”We've just released a critical trade alert about a groundbreaking AI investment opportunity. So, I wanted t...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexicon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexicon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LXRX Stock Alerts